BlogHeader.png

Alcami Pays Tribute to Fallen Patriots this Memorial Day

Alcami joined the nation in remembering and honoring fallen members of the U.S. Armed Forces this Memorial Day with a donation to the Purple Heart Foundation and a strong public showing of support for longtime Alcami employee and Vietnam veteran, Herman Anthony.

In a special tribute to the brave men and women who sacrificed their lives in service to our country, Anthony was invited by the Milwaukee Brewers to participate in a May 26 ceremony on the Miller Park playing field during the national anthem.

Topics: Company News Alcami in Action

Alcami Supports Homestead High School’s Varsity Robotics Club

Alcami continues to make science, technology, engineering, and mathematics (STEM) education and training initiatives a priority in 2019, this time partnering with Homestead High School in Mequon, Wisconsin, to support the school’s growing robotics club. The company has agreed to sponsor Homestead’s 2019 competitions and demonstrations, which will help its club purchase new computers and 3D printers. On average, teams invest approximately $4,000 to build a robot from the ground up and participate in competitions.

Topics: Company News Alcami in Action

Alcami and Students 2 Science Inspire Future Scientists

Students 2 Science (S2S) is a New Jersey-based nonprofit committed to inspiring and educating elementary, middle, and high school students to pursue careers in science, technology, engineering, and mathematics (STEM). Through strategic partnerships between businesses, institutions of higher education, district leadership, and workforce-readiness agencies, S2S provides students with real life laboratory problem-solving experiences led by scientific professionals using modern technology and instrumentation. S2S’s V-Laboratory educational program enlists corporate partners such as Alcami to serve as in-class mentors and help introduce students to the broad spectrum of STEM careers available to them.

Topics: Company News Alcami in Action

Alcami St. Louis Facility Issued European Medicines Agency Certification

Alcami’s St. Louis, Missouri Center of Excellence for advanced analytical testing was issued a Certificate of Compliance by the European Medicines Agency (EMA) Tuesday, April 23, 2019, following the facility’s recent successful Good Manufacturing Practice (GMP) inspection. Certification confirms the site is compliant with GMP laboratory storage and testing practices, and enables the laboratory to process more commercial products for the European Union (EU). The outcome reflects the company’s unwavering commitments to quality, reliability, responsible operations, and strict adherence to regulatory compliance.

Topics: Company News Regulatory Compliance Analytical Testing Analytical Development

Alcami Celebrates Earth Day with Community Cleanups

Alcami employees, their families, and friends celebrated Earth Day 2019 by cleaning up green spaces, beaches, waterways, sidewalks, and streets in the company’s local communities. More than 30 volunteers participated in this year’s preservation efforts, including cleanups at Wrightsville Beach, Carolina Beach, and Isle of Palms Beach, near Wilmington, North Carolina and Charleston, South Carolina; business park and nature trail litter removal in Germantown, Wisconsin; and growing new plant life in Durham, North Carolina. Combined, these efforts will protect native wildlife and enhance public gathering places for all to enjoy.

Topics: Company News Alcami in Action

Video: Extractables and Leachables

Over the years, the US Pharmacopeia (USP), International Harmonisation (ICH), Product Quality Research Institute (PQRI), and several other industry consortia have developed guidelines and best practices for these extractables & leachables studies.

Alcami has specialized knowledge of the most common materials of construction such as platinum-cured silicon, halobutyl rubber, cyclic olefins, polyethylene terephthalate (PET), polyvinyl chloride (PVC), and other elastomers. Vial and stopper configurations, spray pumps, and intravenous (IV) bags are among the most common packaging system components we evaluate. We welcome all routes of administration, including the more challenging prefilled syringes, blow-fill sealed vials, and laminated cans.

Topics: Company News Extractables & Leachables Analytical Development Drug Product Extractables Studies Videos

Alcami Kickstarts Biologics Enterprise to Advance Treatments for Complex Medical Conditions

Durham, NC (USA) – March 19, 2019 – Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today launched Alcami Biologics, the organization’s new biopharmaceutical development, analytical testing, manufacturing, and packaging enterprise. Alcami Biologics will advance the commercialization of a wide range of biological products to treat complex medical conditions with unmet needs. This comes in response to increased market demand for outsourced biological drug development services.

Topics: Company News Biologics Manufacturing Analytical Testing Development Analytical Development Packaging Drug Product Parenteral Manufacturing

Connect Faster: Introducing Alcami RightNow™

Alcami is connecting with its customers faster with the launch of Alcami RightNow™, the company’s new convenient and responsive web-based live chat function.

The latest in the company’s growing customer experience enhancements, Alcami RightNow grants existing clients, prospective partners, and information seekers immediate answers to questions and quick access to materials, resources, and relevant content by directly communicating with live Alcami experts.

Topics: Company News Resource Center Alcami RightNow

Editorial: Fuelling Pharma's Innovation Engines

Alcami President & Chief Executive Officer Dr. Stephan Kutzer recently took part in an interview for Manufacturing Chemist titled "Fuelling Pharma's Innovation Engines." 

According to Stephan, small and mid-size pharma and biologics companies are the innovation engines of the industry. “Each year, the number of new INDs and NDAs increases and we anticipate this trajectory to continue. We see more than 5000 clinical introductions on an annual basis. Cancer treatments are a particular area of focus for many of our clients and we expect our pipeline for these therapies to grow within the next 5 years. Our target accessible market is around $8 billion.”

KR: How does Alcami plan to grow with the industry?

SK: We have strategically invested in capability extensions and operational excellence initiatives to better meet industry demand. At our Germantown (Wisconsin, USA) Center of Excellence for API development, scale-up and commercialisation, we have supplemented our existing pipeline with HPAPI suites and controlled substance capabilities.

Topics: Company News Thought Leadership Editorials

Video: Alcami's Oral Solid Dose Manufacturing

Your Manufacturing Milestones Matter.
Specialized to manufacture oral solid dose (OSD) forms, Alcami’s Wilmington, North Carolina site supports preclinical production through commercial launch and supply. Our cGMP manufacturing technologies, including low/high shear granulation and fluid bed drying capabilities, are arranged in flexible suites to support novel, advanced, and complex projects. 

In addition to OSD development and manufacturing, Alcami’s in-house analytical, stability, and packaging services provide an integrated and custom-tailored offering to help your product reach patients sooner.

Topics: Company News Oral Solid Dose Drug Product Videos